NiceProt View of SWISS-PROT: P11362

[General] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

General information about the entry

Entry name

FGR1_HUMAN

Primary accession number

P11362

Secondary accession number(s)

P17049

Entered in SWISS-PROT in

Release 11, July 1989

Sequence was last modified in

Release 18, May 1991

Annotations were last modified in

Release 38, July 1999

Name and orig in of the protein

Protein name

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1 [Precursor]

Synonym(s)

BFGF-R
EC 2.7.1.112
FMS-LIKE TYROSINE KINASE-2
C-FGR

Gene name(s)

FGFR1 OR FLG OR FGFBR OR FLT2

From

Homo sapiens (Human)

Taxonomy

Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Mammalia; Eutheria; Primates; Catarrhini; Hominidae; Homo.

References

[1]
SEQUENCE FROM N.A.
TISSUE=PLACENTA;
MEDLINE; 90245600. [NCBI, ExPASy, Israel, Japan]
Isacchi A., Bergonzoni L., Sarmientos P.;
"Complete sequence of a human receptor for acidic and basic fibroblast growth factors.";
Nucleic Acids Res. 18:1906-1906(1990).

[2]
SEQUENCE FROM N.A.
TISSUE=NEONATAL BRAIN STEM;
MEDLINE; 90360977. [NCBI, ExPASy, Israel, Japan]
Dionne C.A., Crumley G.R., Bellot F., Kaplow J.M., Searfoss G., Ruta M., Burgess W.H., Jaye M., Schlessinger J.;
"Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors.";
EMBO J. 9:2685-2692(1990).

[3]
SEQUENCE FROM N.A.
MEDLINE; 92282615. [NCBI, ExPASy, Israel, Japan]
Hattori Y., Odagiri H., Katoh O., Sakamoto H., Morita T., Shimotohno K., Tobinai K., Sugimura T., Terada M.;
"K-sam-related gene, N-sam, encodes fibroblast growth factor receptor and is expressed in T-lymphocytic tumors.";
Cancer Res. 52:3367-3371(1992).

[4]
SEQUENCE FROM N.A.
TISSUE=LIVER;
MEDLINE; 91126480. [NCBI, ExPASy, Israel, Japan]
Hou J., Kan M., McKeehan K., McBride G., Adams P., McKeehan W.L.;
"Fibroblast growth factor receptors from liver vary in three structural domains.";
Science 251:665-668(1991).

[5]
SEQUENCE FROM N.A.
MEDLINE; 92118399. [NCBI, ExPASy, Israel, Japan]
Kiefer M.C., Baird A., George-Nascimento C., Nguyen T., Mason O.B., Boley L.J., Valenzuela P., Barr P.J.;
"Molecular cloning of a human basic fibroblast growth factor receptor cDNA and expression of a biologically active extracellular domain in a baculovirus system.";
Growth Factors 5:115-127(1991).

[6]
SEQUENCE FROM N.A.
TISSUE=PLACENTA;
MEDLINE; 90290512. [NCBI, ExPASy, Israel, Japan]
Itoh N., Terachi T., Ohta M., Seo M.K.;
"The complete amino acid sequence of the shorter form of human basic fibroblast growth factor receptor deduced from its cDNA.";
Biochem. Biophys. Res. Commun. 169:680-685(1990).

[7]
SEQUENCE OF 201-822 FROM N.A.
Ruta M., Howk R., Ricca G., Drohan W., Zabelshansky M., Laureys G., Barton D.E., Francke U., Schlessinger J., Givol D.;
"A novel protein tyrosine kinase gene whose expression is modulated during endothelial cell differentiation.";
Oncogene 3:9-15(1988).

[8]
SEQUENCE FROM N.A., AND ALTERNATIVE SPLICING.
MEDLINE; 90355989. [NCBI, ExPASy, Israel, Japan]
Johnson D.E., Lee P.L., Lu J., Williams L.T.;
"Diverse forms of a receptor for acidic and basic fibroblast growth factors.";
Mol. Cell. Biol. 10:4728-4736(1990).

[9]
ALTERNATIVE SPLICING.
MEDLINE; 91141499. [NCBI, ExPASy, Israel, Japan]
Gutkind S.J., Link D.C., Katamine S., Lacal P., Miki T., Ley T.J., Robbins K.C.;
"A novel c-fgr exon utilized in Epstein-Barr virus-infected B lymphocytes but not in normal monocytes.";
Mol. Cell. Biol. 11:1500-1507(1991).

[10]
SEQUENCE FROM N.A., AND ALTERNATIVE SPLICING.
TISSUE=LUNG;
MEDLINE; 91319400. [NCBI, ExPASy, Israel, Japan]
Eisemann A., Ahn J.A., Graziani G., Tronick S.R., Ron D.;
"Alternative splicing generates at least five different isoforms of the human basic-FGF receptor.";
Oncogene 6:1195-1202(1991).

[11]
SEQUENCE FROM N.A.
Wennstroem S., Sandstroem C., Claesson-Welsh L.;
Submitted (JUL-1990) to the EMBL/GenBank/DDBJ databases.

[12]
MUTAGENESIS OF TYR-766.
MEDLINE; 92357144. [NCBI, ExPASy, Israel, Japan]
Peters K.G., Marie J., Wilson E., Ives H.E., Escobedo J., del Rosario M., Mirda D., Williams L.T.;
"Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis.";
Nature 358:678-681(1992).

[13]
MUTAGENESIS OF TYR-766.
MEDLINE; 92357145. [NCBI, ExPASy, Israel, Japan]
Mohammadi M., Dionne C.A., Li W., Lin N., Spivak T., Honegger A.M., Jaye M., Schlessinger J.;
"Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis.";
Nature 358:681-684(1992).

[14]
X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 464-762.
MEDLINE; 96361355. [NCBI, ExPASy, Israel, Japan]
Mohammadi M., Schlessinger J., Hubbard S.R.;
"Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism.";
Cell 86:577-587(1996).

[15]
X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 464-762.
MEDLINE; 97284786. [NCBI, ExPASy, Israel, Japan]
Mohammadi M., McMahon G., Sun L., Tang C., Hirth P., Yeh B.K., Hubbard S.R., Schlessinger J.;
"Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors.";
Science 276:955-960(1997).

[16]
VARIANT PFEIFFER SYNDROME ARG-252.
MEDLINE; 95179173. [NCBI, ExPASy, Israel, Japan]
Muenke M., Schell U., Hehr A., Robin N.H., Losken H.W., Schinzel A., Pulleyn L.J., Rutland P., Reardon W., Malcolm S., Winter R.M.;
"A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome.";
Nat. Genet. 8:269-274(1994).

Comments

  • FUNCTION: RECEPTOR FOR BASIC FIBROBLAST GROWTH FACTOR. A SHORTER FORM OF THE RECEPTOR COULD BE A RECEPTOR FOR ACIDIC FGF (AFGF).
  • CATALYTIC ACTIVITY: ATP + PROTEIN TYROSINE = ADP + PROTEIN TYROSINE PHOSPHATE.
  • SUBCELLULAR LOCATION: TYPE I MEMBRANE PROTEIN.
  • ALTERNATIVE PRODUCTS: MANY FORMS OF FGFR1 ARE PRODUCED BY ALTERNATIVE SPLICING. THE FORM SHOWN HERE IS KNOWN AS ALPHA-A1.
  • DISEASE: DEFECTS IN FGFR1 ARE ONE OF THE CAUSES OF PFEIFFER SYNDROME, ALSO CALLED ACROCEPHALOSYNDACTYLY TYPE V (ACS V), CHARACTERIZED BY CRANIOSYNOSTOSIS (PREMATURE FUSION OF THE SKULL SUTURES) WITH DEVIATION AND ENLARGEMENT OF THE THUMBS AND GREAT TOES, BRACHYMESOPHALANGY, WITH PHALANGEAL ANKYLOSIS AND A VARYING DEGREE OF SOFT TISSUE SYNDACTYLY.
  • SIMILARITY: BELONGS TO THE FIBROBLAST GROWTH FACTOR RECEPTOR FAMILY.
  • SIMILARITY: CONTAINS 3 IMMUNOGLOBULIN-LIKE DOMAINS.

Copyright

This SWISS-PROT entry is copyright. It is produced through a collaboration between the Swiss Institute of Bioinformatics and the EMBL outstation - the European Bioinformatics Institute. There are no restrictions on its use by non-profit institutions as long as its content is in no way modified and this statement is not removed. Usage by and for commercial entities requires a license agreement (See http://www.isb-sib.ch/announce/ or send an email to license@isb-sib.ch).

Cross-references

EMBL

X51803; CAA36101.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
X52833; CAA37015.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
X66945; CAA47375.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
Y00665; CAA68679.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
M37722; AAA75007.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
M60485; AAA35840.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
M63887; AAA35958.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
M34185; AAA35836.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
M34186; AAA35837.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
X57118; CAA40400.1; ALT_TERM. [EMBL / GenBank / DDBJ] [CoDingSequence]
X57119; CAA40401.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
X57120; CAA40402.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
X57121; CAA40403.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
X57122; CAA40404.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
M34641; AAA35835.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
A29216; CAA01958.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]

PIR

S11692; TVHUFG.
S25420; S25420.
S26739; S26739.

PDB

1FGK; 23-JUL-97. [ExPASy / RCSB]
1FGI; 08-APR-98. [ExPASy / RCSB]
1AGW; 25-MAR-98. [ExPASy / RCSB]

SWISS-3DIMAGE

FGR1_HUMAN.

MIM

136350; -.
101600; -.

GeneCards

FGFR1.

PRINTS

PR00109; TYRKINASE.

PROSITE

PS00107; PROTEIN_KINASE_ATP; 1.
PS00109; PROTEIN_KINASE_TYR; 1.
PS50011; PROTEIN_KINASE_DOM; 1.

PFAM

PF00047; ig; 3.
PF00069; pkinase; 1.

PRODOM

[Domain structure / List of seq. sharing at least 1 domain]

BLOCKS

P11362.

DOMO

P11362.

PROTOMAP

P11362.

PRESAGE

P11362.

SWISS-2DPAGE

GET REGION ON 2D PAGE.

Keywords

Receptor; Glycoprotein; Tyrosine-protein kinase; ATP-binding; Transferase; Phosphorylation; Transmembrane; Signal; 3D-structure; Immunoglobulin domain; Alternative splicing; Disease mutation.

Features


SIGNAL        1     21       POTENTIAL.
                  
CHAIN 22 822 BASIC FIBROBLAST GROWTH FACTOR RECEPTOR
1. DOMAIN 22 376 EXTRACELLULAR (POTENTIAL).
TRANSMEM 377 397 POTENTIAL.
DOMAIN 398 822 CYTOPLASMIC (POTENTIAL).
DOMAIN 48 108 IG-LIKE DOMAIN.
DOMAIN 171 237 IG-LIKE DOMAIN.
DOMAIN 270 348 IG-LIKE DOMAIN.
DOMAIN 478 767 PROTEIN KINASE.
NP_BIND 484 492 ATP (BY SIMILARITY).
BINDING 514 514 ATP (BY SIMILARITY).
ACT_SITE 623 623 BY SIMILARITY.
MOD_RES 654 654 PHOSPHORYLATION (AUTO-) (BY SIMILARITY).
MOD_RES 766 766 PHOSPHORYLATION (AUTO-).
MUTAGEN 766 766 Y->F: FAILS TO INTERACT WITH PLC-GAMMA.
DISULFID 55 101 POTENTIAL.
DISULFID 178 230 POTENTIAL.
DISULFID 277 341 POTENTIAL.
CARBOHYD 77 77 POTENTIAL.
CARBOHYD 117 117 POTENTIAL.
CARBOHYD 227 227 POTENTIAL.
CARBOHYD 240 240 POTENTIAL.
CARBOHYD 264 264 POTENTIAL.
CARBOHYD 296 296 POTENTIAL.
CARBOHYD 317 317 POTENTIAL.
CARBOHYD 330 330 POTENTIAL.
VARSPLIC 1 160 MISSING (IN ISOFORM GAMMA A1).
VARSPLIC 31 119 MISSING (IN ISOFORM BETA A1 AND ISOFORM
BETA B1). VARSPLIC 428 429 MISSING (IN ISOFORM ALPHA B1, ISOFORM
BETA B1 AND ISOFORM GAMMA B1). VARSPLIC 148 149 MISSING (IN A FORM).
VARIANT 252 252 P -> R (IN PFEIFFER SYNDROME).
/FTId=VAR_004111. CONFLICT 24 24 S -> C (IN REF. 4).
CONFLICT 192 192 K -> E (IN REF. 8).
CONFLICT 194 194 G -> S (IN REF. 11).
CONFLICT 308 308 V -> A (IN REF. 4).
CONFLICT 364 364 E -> Q (IN REF. 7).
CONFLICT 469 469 P -> L (IN REF. 6).
CONFLICT 817 817 G -> R (IN REF. 1).
SEVIEWER logo FT table viewer

Sequence information

Length: 822 AA [This is the length of the unprocessed precursor]

Molecular weight: 91867 Da [This is the Mw of the unprocessed precursor]

CRC64: 93A01B5D78C3E72C [This is a checksum on the sequence]

        10         20         30         40         50         60 
         |          |          |          |          |          | 
MWSWKCLLFW AVLVTATLCT ARPSPTLPEQ AQPWGAPVEV ESFLVHPGDL LQLRCRLRDD
                  
        70         80         90        100        110        120 
         |          |          |          |          |          | 
VQSINWLRDG VQLAESNRTR ITGEEVEVQD SVPADSGLYA CVTSSPSGSD TTYFSVNVSD
                  
       130        140        150        160        170        180 
         |          |          |          |          |          | 
ALPSSEDDDD DDDSSSEEKE TDNTKPNRMP VAPYWTSPEK MEKKLHAVPA AKTVKFKCPS
                  
       190        200        210        220        230        240 
         |          |          |          |          |          | 
SGTPNPTLRW LKNGKEFKPD HRIGGYKVRY ATWSIIMDSV VPSDKGNYTC IVENEYGSIN
                  
       250        260        270        280        290        300 
         |          |          |          |          |          | 
HTYQLDVVER SPHRPILQAG LPANKTVALG SNVEFMCKVY SDPQPHIQWL KHIEVNGSKI
                  
       310        320        330        340        350        360 
         |          |          |          |          |          | 
GPDNLPYVQI LKTAGVNTTD KEMEVLHLRN VSFEDAGEYT CLAGNSIGLS HHSAWLTVLE
                  
       370        380        390        400        410        420 
         |          |          |          |          |          | 
ALEERPAVMT SPLYLEIIIY CTGAFLISCM VGSVIVYKMK SGTKKSDFHS QMAVHKLAKS
                  
       430        440        450        460        470        480 
         |          |          |          |          |          | 
IPLRRQVTVS ADSSASMNSG VLLVRPSRLS SSGTPMLAGV SEYELPEDPR WELPRDRLVL
                  
       490        500        510        520        530        540 
         |          |          |          |          |          | 
GKPLGEGCFG QVVLAEAIGL DKDKPNRVTK VAVKMLKSDA TEKDLSDLIS EMEMMKMIGK
                  
       550        560        570        580        590        600 
         |          |          |          |          |          | 
HKNIINLLGA CTQDGPLYVI VEYASKGNLR EYLQARRPPG LEYCYNPSHN PEEQLSSKDL
                  
       610        620        630        640        650        660 
         |          |          |          |          |          | 
VSCAYQVARG MEYLASKKCI HRDLAARNVL VTEDNVMKIA DFGLARDIHH IDYYKKTTNG
                  
       670        680        690        700        710        720 
         |          |          |          |          |          | 
RLPVKWMAPE ALFDRIYTHQ SDVWSFGVLL WEIFTLGGSP YPGVPVEELF KLLKEGHRMD
                  
       730        740        750        760        770        780 
         |          |          |          |          |          | 
KPSNCTNELY MMMRDCWHAV PSQRPTFKQL VEDLDRIVAL TSNQEYLDLS MPLDQYSPSF
                  
       790        800        810        820
         |          |          |          |
PDTRSSTCSS GEDSVFSHEP LPEEPCLPRH PAQLANGGLK RR
                  
                  

P11362 in FASTA format

View entry in original SWISS-PROT format
View entry in raw text format (no links)
Report form for errors/updates in this SWISS-PROT entry


ISREC logo

Direct BLAST2 submission at EMBnet-CH (Lausanne, Switzerland)

NCBI logo

Direct BLAST submission at NCBI (Bethesda, USA)

PROSITE logo

ScanProsite , ProfileScan

Tools

Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, Dotlet (Java)new

SEVIEWER logo

Feature table viewer (Java)

SWISS-MODEL

Search the SWISS-MODEL Repository